In mice, apolipoprotein A-II (apoA-II) self-associates to form amyloid fibrils (AApoAII) in an age-associated manner. We postulated that the two most important factors in apoA-II amyloidosis are the Apoa2 c allele, which codes for the amyloidogenic protein APOA2C (Gln5, Ala38) and transmission of amyloid fibrils. To characterize further the contribution of the Apoa2 c allele to amyloidogenesis and improve detection of amyloidogenic materials, we established transgenic mice that overexpress APOA2C protein under the cytomegalovirus (CMV) immediate early gene (CMV-IE) enhancer/ chicken b promoter. Compared to transgene negative (Tg À/À ) mice that express apoA-II protein mainly in the liver, mice homozygous (Tg þ / þ ) and heterozygous (Tg þ /À ) for the transgene express a high level of apoA-II protein in many tissues. They also have higher plasma concentrations of apoA-II, higher ratios of ApoA-II/apolipoprotein A-I (ApoA-I) and higher concentrations of high-density lipoprotein (HDL) cholesterol. Following injection of AApoAII fibrils into Tg þ / þ mice, amyloid deposition was observed in the testis, liver, kidney, heart, lungs, spleen, tongue, stomach and intestine but not in the brain. In Tg þ / þ mice, but not in Tg À/À mice, amyloid deposition was induced by injection of less than 10 À8 mg AApoAII fibrils. Furthermore, deposition in Tg þ / þ mice occurred more rapidly and to a greater extent than in Tg À/À mice. These studies indicate that increased levels of APOA2C protein lead to earlier and greater amyloid deposition and enhanced sensitivity to the transmission of amyloid fibrils in transgenic mice. This transgenic mouse model should prove valuable for studies of amyloidosis.
Amyloidosis is a group of diseases caused by structural disorders of proteins whereby normally soluble proteins are deposited in tissues as highly ordered, insoluble amyloid fibrils made up of b-pleated sheets. 1 Several serious human diseases are associated with amyloid fibril deposition such as Alzheimer's disease, type II diabetes, prion disease and familial amyloid polyneuropathy. 2, 3 Several apolipoprotein family proteins have been identified as major components of amyloid fibrils. Apolipoprotein serum amyloid A (ApoSAA), apolipoprotein A-I (apoA-I), apolipoprotein A-II (apoA-II) and apolipoprotein A-IV (apoA-IV) are currently considered to be amyloidogenic apolipoproteins. In mice, apoA-II, the second most abundant apolipoprotein in serum high-density lipoprotein (HDL), associates to form amyloid fibrils (AApoAII) and is deposited in the body, though not in brain, in an age-associated manner. 4, 5 In laboratory mice, three major alleles (Apoa2 a , Apoa2 b and Apoa2 c ) of the apoA-II gene encode three variants of the apoA-II protein: APOA2A with Pro5 and Met26, APOA2B with Pro5 and Val38 and APOA2C with Gln5 and Ala38, respectively. 6, 7 Several genetic analyses have indicated that the Apoa2 c allele might markedly accelerate age-associated deposition of AApoAII. [8] [9] [10] Previously, we have described prion-like transmission of AApoAII amyloidosis in which intravenous, peripheral and oral injection of AApoAII amyloid fibrils markedly accelerated amyloid deposition in young R1.P1-Apoa2 c mice. 11, 12 We also observed that young R1.P1-Apoa2 c mice showed rapid onset of amyloidosis when they share cages with old R1.P1-Apoa2 c mice with severe amyloid deposits. Furthermore, offspring nursed by amyloidosis-induced mothers showed early development of amyloidosis. 12, 13 The propagation of amyloidosis among mice probably occurred through the consumption of AApoAII fibrils contained in feces and milk. Injection of AApoAII fibrils also induced amyloidosis in less-amyloidogenic mouse strains with Apoa2 a or Apoa2 b alleles. 13, 14 Injection of various kinds of amyloid fibrils into R1.P1-Apoa2 c mice also induced amyloidosis. 15 These results demonstrated that a common amyloid fibril structure could serve as a seed for amyloid fibril formation (cross-seeding) in vivo. Prion-like transmission was also reported in mouse inflammation-associated amyloid A (AA) amyloidosis. 16, 17 Many factors such as aging, primary sequence and mutation of amyloid proteins, genetic background of patients, as well as epigenetic factors, including inflammation, food composition and rearing conditions, may influence fibril formation and deposition in tissues. Transmission of amyloid fibrils from the environment may influence fibril formation as an important epigenetic factor. 18 The R1.P1-Apoa2 c strain has been a valuable model system for the investigation of genetic and epigenetic factors in amyloid deposition. However, at least 2-3 months are required to evaluate the degree of amyloid deposition even after the injection of AApoAII fibrils. In addition, it has been shown that the efficiency with which amyloid fibrils induce amyloidosis is significantly decreased by cross-seeding compared to self-seeding by homologous amyloid fibrils. [19] [20] [21] In fact, the rate of fibril formation is dependent on the concentration of amyloid protein both in vitro and in vivo. To develop an advanced model for investigating the mechanism of amyloidosis, we established a transgenic mouse strain that overexpresses amyloidogenic Apoa2 c mRNA. In this study of mApoa2 c transgenic mice, we found that treatment with a very small quantity of amyloid fibrils led to greater amyloid deposition and higher levels of plasma apoA-II compared to non-transgenic mice.
MATERIALS AND METHODS Establishment of Apoa2
c Transgenic Mouse cDNA of the mouse Apoa2 c gene was isolated by reverse transcription-PCR (RT-PCR) of messenger RNA extracted from R1.P1-Apoa2 c mouse liver. The pmApoa2 c -CAGGS vector DNA containing mouse Apoa2 c cDNA inserted between cytomegalovirus (CMV) immediate early gene (CMV-IE) enhancer/chicken b-actin promoter and rabbit b-globin polyA signal 22 was microinjected into fertilized eggs of BDF2 mice. Then, the eggs were transplanted into the uteri of pseudo-pregnant ICR mice. Transgenic founders were identified by PCR using primers for Apoa2-1 (5 0 -AGGAATTC CATCATGAAGCTGCTCGC-3 0 ) and rbGlb-R (5 0 -TAGCCA GAAGTCAGATGCTC-3 0 ). These primers can distinguish positive and negative mice by amplifying a 495 bp fragment of the transgene (Figure 1a ). Since BDF2 mice have a less amyloidogenic Apoa2 a allele, the founder mice were crossed with R1.P1-Apoa2 c , a congenic strain of mice with Apoa2 c from the senescence-accelerated mouse prone strain (SAMP1) on the genetic background of the senescenceaccelerated mouse-resistant strain (SAMR1), to make transgenic mice homozygous for the Apoa2 c allele (
c/c ). To minimize the possible effects of the genetic background, transgenic mice were backcrossed with R1.P1-Apoa2 c mice for six generations. The Apoa2 c allele was identified using allele c-specific primers of A2/acc-F (5 0 -AAGAGACAGGCGGACGGACA-3 0 ) and A2/acc-R (5 0 -GAGGTCTTGGCCTTCTCCAC-3 0 ). Seven transgene-positive founders were obtained, but only one founder (I-6) could pass the transgene to the next generation. Thus, all studies were in a line derived from founder I-6.
Mice were maintained under specific pathogen free (SPF) conditions at 24721C with a light-controlled regimen (12 h light/dark cycle) in the Division of Laboratory Animal Research, Department of Life Science, Research Center for Human and Environment Science, Shinshu University. A commercial diet containing 5.3% fat (MF; Oriental Yeast, Tokyo, Japan) and tap water were available ad libitum. All experiments were performed with the consent of the Animal Care and Use Committee of Shinshu University School of Medicine.
Chromosome Localization of the Integrated Apoa2 c cDNA Vector The location of the inserted Apoa2 c cDNA vector in the chromosome was determined by chromosome walking according to the protocol of the DNA Walking SpeedUp Kit (Seegene Inc., Seoul, Korea). We used two PCRs to amplify genomic DNA upstream of the inserted transgene in the transgenic mice. In the first PCR, we used the primers of DW-ACP2 (5 0 -ACP-TGGTC-3 0 ) and R203 (5 0 -CCATT-GACGTCAATGGAAAGTCC-3 0 ). Cycling conditions were as follows: one cycle at 941C for 30 s; 30 cycles at 941C for 40 s, 551C for 40 s, 721C for 2 min; and one cycle at 721C for 7 min. The second PCR was performed on 2 ml of PCR product from the first round of PCR with the second set of primers, DW-ACP-N (5 0 -ACPN-GGTC-3 0 ) and R180 (5 0 -CTATTGGCGTTACTATGGGAACATACG-3 0 ) ( Figure  1a ). Cycling conditions for the second round of PCR were as follows: one cycle at 941C for 30 s; 30 cycles at 941C for 40 s, 601C for 40 s, 721C for 2 min; and one cycle at 721C for 7 min. PCR products were resolved on 2% agarose gels. Next, we used the same method to amplify sequences downstream of the inserted cDNA using primers F2381 (5 0 -GCCTAAT GAGTGAGCTAACTCAC-3 0 ) and 13-L1-F (5 0 -CACCTGAA AAAATGTTCAACATCCTTAG-3 0 ). We determined their location in the chromosome by comparing their sequences with the draft sequence of the mouse genome.
We also performed PCRs using the primers of 13F (5 0 -GCAAGCAGTGTCCAGTTAGG-3 0 ) and R112 (5 0 -CCA GGCGGGCCATTTACCGTAAGT-3 0 ) and with the primers of 13F and 13R (5 0 -CAGGCTCATACTACTTGCAG-3 0 ) to distinguish homozygous, heterozygous and negative mice (Figure 1b) .
Analysis of the Expression of apoA-II in the Transgenic Mice Total RNA was extracted from mouse organs using QIAamp RNA Mini Kits (Qiagen Inc., Valencia, CA, USA) according to manufacturer's protocol. First strand cDNA was synthesized using ReverTra Ace-á kit (Toyobo, Ltd, Osaka, Japan) and used in PCR. We used primers Apoa2-1 (5 0 -AGGAA TTCCATCATGAAGCTGCTCGC-3 0 ) and Apoa2-2 (5 0 -AGG AATTCCTCACTTAGCCGCAGGAGC-3 0 ) for RT-PCR of the apoA-II mRNA transcribed from endogenous apoA-II gene and transgene. We used primers cbAct-F (5 0 -ACT-GACCGCGTTACTCCCAC-3 0 ) and Apoa2-2 for the apoA-II mRNA transcribed from transgene ( Figure 1a) . We carried out RT-PCR for the housekeeping gene b-actin using primers mbAct-F (5 0 -ACAATGAGCTGCGTGTGGCC-3 0 ) and mbAct-R (5 0 -CCTCGTAGATGGGCACAGTG-3 0 ).
Following perfusion with PBS, organs were removed from mice and maintained at À801C until proteins could be extracted for western blot analysis of apoA-II protein. 23 Samples were loaded on Tris-Tricine/SDS-16.5% polyacrylamide gels electrophoresis (PAGE) as follows: 50 mg of protein extracted from the testis, liver, kidney, heart, lungs, spleen, tongue and stomach, 100 mg from brain and intestine and 0.1 ml of the plasma. 24 After electrophoresis at 15 mA for 6 h, proteins were transferred to a polyvinylidene difluoride membrane using a semidry western blot apparatus (Nihon Eido, Tokyo, Japan) at 150 mA for 1.5 h. The membrane was then reacted with primary antibody solution, either with polyclonal rabbit anti-mouse apoA-I (diluted 1:2000) or apoA-II antisera (diluted 1:4000) in 5% skim milk in PBS containing 0.1% Tween 20 (T-PBS) for 1 h at room temperature with gentle shaking. 25 Membranes were incubated Figure 1a ) recognizing wild-type genomic sequence were used to distinguish Tg
Amyloidosis in apoA-II transgenic mice F Ge et al for 1 h with horseradish peroxidase (HRP)-conjugated antirabbit IgG (Daiichi Pure Chemicals, Tokyo, Japan) solution (1:500). ApoA-I and apoA-II were detected by the enhanced chemiluminescence (ECL) method (Amersham International, Buckinghamshire, UK) and quantitated using a densitometric image analyzer with NIH Images Ver. 1.61.
Plasma Lipids, Lipoprotein Quantity and HDL Particle Size Plasma was collected from mice that had fasted overnight. Plasma total cholesterol levels were determined by an enzymatic procedure (cholesterol C test, Wako Pure Chemical Industries, Osaka, Japan). HDL cholesterol was estimated according to a modified heparin-manganese precipitation procedure (HDL-cholesterol Test, Wako). To determine the HDL particle size, plasma (3 ml) pre-stained for lipids by Sudan Black B was electrophoresed on a nondenaturing PAGE gel containing a 5-15% linear polyacrylamide gradient. 26 Electrophoresis was carried out at 25 mA for 2 h. The distribution of apoA-II protein among the HDL species was determined by western blot analysis of 0.1 ml plasma separated by native PAGE. Cholesterol profile in plasma lipoproteins was analyzed by a dual detection high performance liquid chromatography (HPLC) system with two tandem TSKgel LipopropakXL columns (300 Å B7.8 mm) according to the method of Usui et al 27 (Liposearch System, Skylight Biotech Inc, Akita, Japan).
Isolation of AApoAII Fibrils and Induction of AApoAII Amyloidosis
AApoAII amyloid fibrils were isolated from the liver of an 18-month-old R1.P1-Apoa2 c mouse with severe amyloidosis as described by Pras et al. 28 The isolated amyloid fibril fraction was further purified by ultracentrifugation as described previously. 11 Pellets after ultracentrifugation were resuspended in distilled water and kept at À701C. For induction of AApoAII amyloidosis, a single dose of 10
À8
, 10
À5
À3
, 10 À1 and 1 mg of sonicated AApoAII amyloid fibrils 13 were injected into the tail vein of 2-month-old transgene positive and negative mice. After 1, 2 and 3 months, the treated mice were killed by cardiac puncture under diethyl ether anesthesia, and amyloid deposition was determined.
Detection of Amyloid Deposition
Deposition of amyloid fibrils was identified by polarizing microscopy using Congo Red-stained sections in which green birefringence indicates the presence of amyloid. 29 Amyloid fibril protein, AApoAII and AA proteins were identified immunohistochemically using the avidin-biotin HRP complex method with specific antiserum against mouse AApoAII or AA. 5 The intensity of the AApoAII amyloid deposition was determined semi-quantitatively using the amyloid index (AI) parameter. The AI parameter represents the average degree of AApoAII deposition, graded 0 to 4, in the seven organs examined (liver, heart, spleen, tongue, stomach, intestine and skin) in Congo Red stained sections. 13 Tissues were examined by two independent observers who were blinded to the experimental protocol.
Transmission Electron Microscopy
Aliquots of 5 ml of amyloid fibril fraction isolated from liver of homozygous mouse treated by AApoAII were diluted with 45 ml distilled water, and 20 ml aliquots of the diluted fraction were applied to 400-mesh collodion-coated copper grids (Nissin EM Co. Ltd, Tokyo, Japan) for 1 min and subjected to negative staining with 20 ml of 1% phosphotungstic acid (pH 7.0) for 1 min. The negative stained samples were observed with an electron microscope (1200 EX; JEOL, Tokyo, Japan) operated at 80 kV. 
Statistical Analysis

RESULTS
Establishment of the mApoa2
c Transgenic Mouse Strain To study the mechanism of amyloidogenesis and to generate a novel model mouse strain with improved sensitivity to amyloidogenic materials in the environment, the amyloidogenic Apoa2 c gene was introduced into the mice. A 320 bp Apoa2 c cDNA fragment was amplified and inserted into the vector between the CMV-IE enhancer/chicken b-actin promoter and the rabbit b-globin polyadenylation site. The construct was linearized with SalI and PstI, then microinjected into fertilized eggs. Transgenic offspring were screened by PCR, using primers specific for the transgene spanning Apoa2 c gene and rabbit b-globin polyadenylation site (Figure 1a) . One line of the founder mice was bred successfully for further studies.
We used the DNA walking PCR procedure with primers annealed to the 5 0 and 3 0 end of the pCAGGS-mApoa2 c vector to localize the integrated chromosomal site. DNA sequencing of the genome surrounding the integrated vector revealed that it integrated near the centromere of chromosome 13 ( Figure 1a ). In association with integration of the vector, intracisternal A particles (IAP) and long interspersed nuclear elements (LINE) were integrated together in tandem and a 4784 bp genomic segment was deleted. Adjoining genes (Pfkp; phosphofructokinase platelet and Adarb2; adenosine deaminase, RNA-specific, B2) are 490 and 1100 kbp away from the integrated site. The results indicated that homozygous Tg þ / þ mice had four additional copies and heterozygous Tg þ /-mice had two extra copies of the Apoa2 c gene in addition to the two endogenous copies (Figure 1a) . We designed primers that recognized deleted chromosomal DNA and integrated vector sequences to distinguish homozygous (Figure 2b ). The amount of apoA-II protein in tissues was analyzed by western blot analysis (Figure 2d ). In Tg À/À mice, apoA-II protein was not detected in brain, stomach or intestine. In Tg þ / þ mice, apoA-II was elevated in all tissues except intestine. Furthermore, Tg þ / þ mice showed higher expression than Tg þ /À mice. . The concentrations of apoA-I and apoA-II proteins were determined by western blot analysis (Figure 3a) . The concentrations of apoA-II were lower in Apoa2 a (C57BL/6J) and Apoa2 c (Tg À/À ) mice. The Apoa2 c transgene increased the concentration of apoA-II in Tg þ /À and Tg þ / þ mice, while apoA-I concentrations were similar between strains. Quantitation of apoA-I and apoA-II levels revealed that the concentration of apoA-II in Tg þ / þ mice, was 1.57-and 1.26-fold greater than in Tg À/À and Tg þ /À mice, respectively. In contrast, significant changes were not observed in apoA-I concentration (Figure 3b) . As a result, the ratio of apoA-II/ apoA-I was much higher in Tg þ / þ mice. Specifically, the ratio of apoA-II/apoA-I for Tg þ / þ mice was 1.65-and 1.36-fold higher than Tg À/À and Tg þ /À mice, respectively (Figure 3c ). Plasma total cholesterol and HDL-cholesterol levels were also determined (Figure 3d ). Total and HDLcholesterol levels were significantly higher in Tg þ /À mice compared to Tg À/À mice and further increased in Tg
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mice to the levels of SAMR1 mice. To determine the effect of additional Apoa2 c expression on lipoprotein particles, we determined lipoprotein particle size by non-denatured PAGE and by gel permeation HPLC analysis. The predominant form observed on non-denaturing PAGE was HDL 3 . The sizes of HDL 3 particles in C57BL/6J and Tg À/À mice were smaller than those in SAMR1 mice (Figure 3e ). Higher concentrations of apoA-II and higher ratios of apoA-II to apoA-I in Tg
and Tg þ / þ mice did not change the particle sizes of HDL 3 . The amount of apoA-II was increased in all HDL 3 , HDL 2 and HDL 1 particles in Tg þ /À and Tg þ / þ mice. HPLC analysis confirmed that the quantity of HDL increased but the size of HDL did not change in Tg þ / þ mice, but the HDL particle size remained smaller than in SAMR1 mice (Figure 3f ).
AApoAII Amyloid Deposition in mApoa2
c Transgenic Mice To induce amyloidosis, sonicated AApoAII amyloid fibrils were injected intravenously into 2-month-old Tg À/À , Tg
and Tg þ / þ mice at doses of 10
À8
À5
, 10 À3 , 10
À1
, and 1 mg. Amyloid deposition in tissues was determined by Congo Red staining and immunohistochemistry after 2 months. In Tg þ / þ mice, injection of 1 mg AApoAII amyloid fibril To analyze amyloid deposition in tissues, we isolated amyloid fibrils from the liver of Tg þ / þ mice treated with AApoAII amyloid fibrils. Western blot analysis identified the protein as AApoAII (Figure 5a ). We observed negatively stained amyloid fibrils by transmission electron microscopy (Figure 5b) , the fibrils were rigid, nonbranching and B10 nm in diameter. We compared the levels of amyloid deposition in the six major organs of spleen, heart, liver, tongue, stomach and intestine using a grading system. 13 In transgenic positive mice, significantly higher amyloid depositions were observed in all organs except for the stomach as compared with Tg À/À mice ( Figure 6 ). No amyloid deposition was observed in the brain in any strain. To quantitate the relative sensitivities of mApoa2 c transgenic mice to induction of amyloidosis by amyloid fibrils, the AApoAII amyloid fibrils were serially diluted in distilled water and injected into the tail vein of Tg À/À , Tg þ /À and Tg þ / þ mice at doses ranging from 10 À8 to 1 mg. Mice were killed 2 months after the injections. The degree of amyloid deposition in the whole body was compared using the AI in the seven organs (Figure 7a ). Small amyloid deposits were found in four of the eight Tg þ / þ mice after injection of 10 À8 mg AApoAII fibrils; no deposition was detected in Tg À/À and Tg þ /À mice. We found amyloid deposition in Tg þ /À and Tg þ / þ mice and no deposition in Tg À/À mice after injection of 10 À5 mg fibrils. When 10 À3 mg, 10 À1 mg and 1 mg AApoAII fibrils were injected, the degree of amyloid deposition increased in a dose-dependent manner in all Tg À/À , Tg þ /À and Tg þ / þ mice. However, AI values were Amyloidosis in apoA-II transgenic mice F Ge et al significantly different between the strains and always in the following order: Tg
Amyloid deposits were observed only in the tongue, spleen, stomach and small intestine at low quantities of injected AApoAII fibrils (10 À8 mg in Tg þ / þ and 10 À3 mg in Tg À/À mice) (Figure 7b ). To characterize the rate at which deposition occurred in mApoa2 c transgenic mice (Tg þ / þ ), AI was determined 1, 2 and 3 months after injection of 1 mg amyloid fibrils ( Figure  7c ). The amyloid deposition was observed in all three strains 1 month after injection. The extent of amyloid deposition (AI) further increased 2 and 3 months after injection. AI values were significantly different between strains and always in the following order: Tg
Amyloid deposition was found systemically in the liver, heart, lungs, spleen, tongue, stomach, intestine and skin in Tg þ / þ mice (Figure 7d ). Amyloid deposition was found only in the tongue, heart and stomach in Tg À/À mice 1 month after injection, but found in the liver, heart, lungs, spleen, tongue, stomach, intestine and skin 3 months after injection. The distribution profiles of amyloid in the organs did not show any difference in all Tg
, Tg þ /À and Tg þ / þ mice. Namely, some particular organs showed earlier deposition, always in this order: tongue, intestine and stomach, spleen and heart, liver.
DISCUSSION
In mice, spontaneous senile apoA-II amyloidosis is universally present. 30 Severe apoA-II amyloidosis is linked to the Apoa2 c allele (Gln5, Ala38). Here, we report the establishment of a new apoA-II transgenic mouse strain that overexpresses the mApoa2 c allele. Our long-term goal is to use this model to elucidate metabolic features of the amyloidogenic Apoa2 c allele and the pathogenesis of amyloidosis. This Amyloidosis in apoA-II transgenic mice F Ge et al strain has much improved sensitivity to induction of amyloidosis by amyloid fibrils. We have previously showed that the degree of senile apoA-II amyloid deposition in mouse strains varied with the apoA-II allele such that Apoa2 c 4Apoa2 a 4Apoa2 b . 13,14 Elucidation of the mechanism by which amyloidogenic apoA-IIs (Apoa2 c and Apoa2 a ) induce a low concentration of HDL should shed light on the pathogenesis of amyloidosis (Figure 3) . We have previously demonstrated that the mRNA level, synthesis rate, plasma clearance rates and translational efficiencies of apoA-II were similar in SAMP1 (Apoa2 c ) and SAMR1 (Apoa2 b ) mice. Impaired secretion was suggested in Apoa2 c mice. 31, 32 Amyloidogenic apoA-IIs may be retained in the endoplasmic reticulum (ER) by the ER quality control system. 33, 34 Overexpression of apoA-II under the CAGGS enhancer/promoter increased plasma apoA-II from 39 mg/dl (Tg À/À ) to 61 mg/dl (Tg þ / þ ) resulting in apoA-II concentration 1.57 times higher than in Tg À/À mice. Increased apoA-II was associated with an increased concentration of HDL and total cholesterol. These results were consistent with those observed in C57BL/6J transgenic mice that overexpressed the Apoa2 a gene 35, 36 and R1.P1-Apoa2 c mice that overexpressed the Apoa2 b gene. 37 Highly expressed apoA-II associated with all species of HDL but mainly with HDL 3 particles. The particle size of HDL did not change in mApoa2 c transgenic mice, different from mice overexpressing Apoa2 b and Apoa2 a . More severe amyloid deposition was observed in the body of Tg þ / þ mice compared to Tg À/À mice. Thus, the plasma concentration of amyloid protein contributes to the progress of systemic apoA-II amyloidosis. In our previous study, we reported that SAMP1 mice that were fed a fish oil diet had significantly lower apoA-II concentrations but more AApoAII deposits than those on a butter and safflower oil diet. 38 These results suggested altered metabolism or clearance of amyloid protein might be another factor controlling susceptibility towards amyloidosis. 39 ApoA-II is synthesized mainly in the liver in mice and secreted to the blood very quickly. Thus, the amount of apoA-II protein in the liver represented by western blot was very low in Tg À/À mice. On the other hand, apoA-II proteins detected in the heart and tongue might be in the blood, whereby perfusion did not wash them away completely. But in Tg þ / þ mice, apoA-II mRNA and proteins were expressed in almost all tissues examined. We have previously suggested a possible contribution of apoA-II synthesized in extrahepatic tissues to local amyloid deposition. 40 We expected that such extrahepatic synthesis might influence tissue distribution of amyloid deposition after fibril injection. However, notable differences were not observed in tissue distribution of amyloid deposi- Comparison of amyloid deposition in major organs of AApoAIItreated mice. The grade of amyloid deposition in the spleen, heart, liver, tongue, stomach, intestine and brain was determined using Congo redstained sections. 13 The degrees of deposition were significantly different among the Tg Amyloidosis in apoA-II transgenic mice F Ge et al tion between Tg þ / þ and Tg À/À mice, even though deposition was heavier and earlier in Tg þ / þ mice. These results suggest that amyloid protein in blood may be the sole major source of amyloid fibrils in each tissue. In particular, we did not find any amyloid deposits in the brain in spite of the expression of apoA-II mRNA and protein in Tg þ / þ mice. We offer three possible explanations: (1) the level of apoA-II protein in the brain was too low to form deposits, (2) the blood-brain barrier prevented the AApoAII fibrils from invading the brain, and (3) other environmental factors such as inflammation were necessary for deposition in the brain. 39 We determined the apoA-II transgene insertion site. Homozygous Tg þ / þ mice had four extra copies of the Apoa2 c gene. The insertion of vector DNA into the centromeric region of chromosome 13 eliminated 4784 bp of genomic DNA accompanied with insertion of transposon elements, IAP and LINE. No genes could be identified in the lost DNA, and the neighboring genes may be too far away to be affected by the CAGGS enhancer/promoter insertion elements. Thus, overexpression of apoA-II under the CAGGS enhancer/promoter is likely to be the cause for the severe amyloid deposition in Tg þ / þ mice. Prion diseases are characterized by abnormal deposits of amyloid fibrils as amyloid plaques which induce neurologic damage. 41, 42 Such fibrils, which are self-propagating protein conformations occurring both in vitro and in vivo, [43] [44] [45] [46] [47] [48] [49] [50] are thus transmissible. When small nuclei or fibril seeds are present, they dramatically accelerate fibril formation by inducing conformational changes in amyloid protein monomers. Thus, in non-prion amyloidosis, the conformational change induced by preexisting amyloid fibrils might make the disease transmissible. did not show spontaneous amyloid deposition until 6 months of age (data not shown). Tg þ / þ and Tg þ /À mice had increased sensitivity to amyloid fibril injection. Amyloid deposition could be detected in Tg þ / þ mice injected with 10 fg of amyloid fibrils. On the other hand, amyloid deposition was detected only in Tg À/À mice injected more than 1 ng of amyloid fibrils (Figure 7a ). Amyloid deposition was detected in many organs in Tg þ / þ mice 1 month after injection of amyloid fibrils (Figure 7d ). Thus the period for detection decreased to less than 1 month compared to Tg À/À mice. 54 Since fibrilization of several kinds of amyloid proteins is nucleation-dependent, self-and cross-seeding by amyloid fibrils and amyloid fibril-like materials is thought to be a key factor for the progress of amyloidosis. To elucidate the pathogenesis of amyloidosis and to prevent it, it is necessary to improve the current bio-assay system for detection of amyloid fibrils and amyloidogenic materials in the environment. Ideally, the system should have a higher sensitivity and shorter waiting period than in R1.P1-Apoa2 c (Tg À/À ) mice. The mechanism by which the injected apoA-II fibrils gain access to the tissue remains to be elucidated. We found that the content of apoA-II in HDL particles did not change after incubation of HDL with sonicated AApoAII amyloid fibrils (data not shown). This suggests that typical or fragmented amyloid fibrils do not associate with HDL particles. We believe amyloid fibrils are too large to associate with HDL particles. In mouse apoA-II amyloidosis following induction by amyloid fibrils, the amyloid first deposits in the tongue, stomach and intestine, then extends to other tissues. A difference in access of the fibrils to different tissues may account for the distribution of the induced amyloidosis. We could not exclude the possibility that HDL and other lipoprotein particles might bind to injected fibrils and contribute to the access of fibrils to certain tissues. The new Apoa2 c transgenic mouse strain with high sensitivity to exogenous amyloid fibrils should be helpful to elucidate such issues.
Several conditions might contribute to the progress of amyloidosis: (1) structures or mutations of amyloid proteins, 18 (2) levels of the amyloid proteins in the blood or local environment in each tissue, (3) transmission of amyloidogenic materials and (4) other environmental conditions such as inflammation, nutrition and aging. In particular, many tissue factors that facilitate the metabolism, aggregation or stability of amyloid fibrils may contribute to a differential tissue distribution of amyloid deposition. Such factors might include the quality control system of proteins in ER, molecular chaperones preventing protein aggregation, proteoglycans increasing fibril stability in the extracellular space and fibril degradation by proteases. Here, we have established a new transgenic mouse strain of an amyloidogenic apoA-II variant (APOA2C), which showed significantly increased sensitivity to induction of amyloidosis associated with an increased concentration of APOA2C. Mouse apoA-II amyloidosis shares many properties with other types of amyloidosis. This line should be a valuable tool to investigate amyloidosis-associated conditions and factors, and should provide important insights into diseases of protein misfolding.
